Hiroaki Ueno

7PUBLICATIONS
23CO-AUTHORS
PharmacogenomicsTraditional Chinese medicine and treatmentsImmunogenetics (incl. genetic immunology)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 21, 2026
Frailty and low body mass index as key determinants of sodium-glucose cotransporter 2 inhibitor-specific adverse event-related discontinuation in adults aged ≥75 years: A multicenter real-world retrospective cohort study.

|Jun 26, 2025
Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD).

Yuta Nakamura, Ichiro Horie, Hiroshi Yano

|May 12, 2023
A Response to Letter to the Editor: Can Imeglimin Improve the Systolic Time Intervals in Diabetes Mellitus?

Taisuke Uchida, Hiroaki Ueno, Ayaka Konagata

|Feb 02, 2023
Improving the Effects of Imeglimin on Endothelial Function: A Prospective, Single-Center, Observational Study.

Taisuke Uchida, Hiroaki Ueno, Ayaka Konagata

|Jan 19, 2022
Current status of diabetes treatment in Miyazaki Prefecture, Japan: Results of a questionnaire survey conducted in 2016 and 2020.

Yudai Uehira, Hiroaki Ueno, Emi Ebihara

|Jul 14, 2019
Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study.

Tomoho Noda, Emi Ebihara, Hiroaki Ueno

Pageof 2

Frequent Collaborators

4 joint publications

Taisuke Uchida

4 joint publications

Hideki Yamaguchi

2 joint publications

Yudai Uehira

2 joint publications

Hiroki Nabekura